Sort
50,496 grants matching “lung cancer”
INDIVIDUALIZED DOSE ESCALATION IN VOLUME-EFFECT ORGANS
$395,478Theodore S Lawrence · University Of Michigan At Ann Arbor · P01 · FY2008 · CA
Project 4: Risk stratification for pulmonary nodules detected by CT imaging using plasma and imaging biomarkers
$395,452Paul D Lampe · Fred Hutchinson Cancer Research Center · P50 · FY2021 · CA
The role of structural variation in promotion, evolution and treatment of various tumor types
$395,435Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Applied Molecular Pathology Laboratory
$395,428Margaret Tucker · Division Of Cancer Epidemiology And Genetics · ZIC · FY2013 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2015 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2013 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2017 · CA
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Safety and Feasibility of Cultivated Autologous Limbal Epithelial Cell (CALEC) Transplantation in the Treatment of Limbal Stem Cell Deficiency
$395,380Jerome Ritz · Dana-Farber Cancer Inst · UG1 · FY2019 · EY
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
$395,349Dana Ashley Hill · Children'S Research Institute · R01 · FY2019 · CA
Novel inhibitor for oncogenic RAS for lung cancer
$395,336Gary A Piazza · Auburn University At Auburn · R01 · FY2023 · CA
Function of PHD Domain Proteins in Chromatin Regulation
$395,313Or P. Gozani · Stanford University · R01 · FY2017 · GM
Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness
$395,280Wael M. Elshamy · San Diego Biomedical Research Institute · R01 · FY2017 · CA
Generalized and Cancer-Related Episodic Future Thinking for Smoking Cessation: Proof-of-Concept and Feasibility Testing
$395,248Jeffrey Scott Stein · Virginia Polytechnic Inst And St Univ · R21 · FY2025 · CA
Oncogenic Function of FBXW7 R465 mutation reveals a new opportunity for cancer therapy
$395,245Suresh Kumar · National Institute On Aging · ZIA · FY2019 · AG
Anti-obesity effects of adipose-targeting resveratrol nanocarriers
$395,239Shu Wang · Texas Tech University · R15 · FY2015 · AT
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$395,217Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
PI3K/PTEN/Akt signaling and the genesis of cancer
$395,208Nissim Hay · University Of Illinois At Chicago · R01 · FY2015 · CA
Growth Factors and Smooth Muscle Cell Lineage During Lung Organogenesis
$395,197Saverio Bellusci · Children'S Hospital Of Los Angeles · R01 · FY2008 · HL
Genetic Susceptibility To Carcinogens and Toxicants
$395,184Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
$395,179Edward Seto · George Washington University · R01 · FY2023 · CA
Mdm2 Alternative Splicing in DNA Damage and Cancer
$395,173Dawn S Chandler · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · CA
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$395,164Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients
$395,140David Hui · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Support for Specimen Banking in ACOSOG
$395,137Monica M Bertagnolli · Brigham And Women'S Hospital · U24 · FY2014 · CA